Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cyclerion Therapeutics (CYCN) Non Operating Income (2020 - 2025)

Historic Non Operating Income for Cyclerion Therapeutics (CYCN) over the last 6 years, with Q3 2025 value amounting to $30000.0.

  • Cyclerion Therapeutics' Non Operating Income fell 9259.26% to $30000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 12267.08%. This contributed to the annual value of $571000.0 for FY2024, which is 5949.72% up from last year.
  • Latest data reveals that Cyclerion Therapeutics reported Non Operating Income of $30000.0 as of Q3 2025, which was down 9259.26% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Cyclerion Therapeutics' Non Operating Income ranged from a high of $1.3 million in Q2 2025 and a low of -$6000.0 during Q2 2021
  • In the last 5 years, Cyclerion Therapeutics' Non Operating Income had a median value of $62000.0 in 2023 and averaged $137526.3.
  • In the last 5 years, Cyclerion Therapeutics' Non Operating Income crashed by 10537.63% in 2021 and then skyrocketed by 1330000.0% in 2022.
  • Cyclerion Therapeutics' Non Operating Income (Quarter) stood at -$1000.0 in 2021, then surged by 13300.0% to $132000.0 in 2022, then fell by 23.48% to $101000.0 in 2023, then plummeted by 72.28% to $28000.0 in 2024, then grew by 7.14% to $30000.0 in 2025.
  • Its last three reported values are $30000.0 in Q3 2025, $1.3 million for Q2 2025, and $28000.0 during Q1 2025.